Display options
Cite
Schaper J, Kostin S, Hein S, et al. Structural remodelling in heart failure. Exp Clin Cardiol. 2002;7(2):64-8
Schaper, J., Kostin, S., Hein, S., Elsässer, A., Arnon, E., & Zimmermann, R. (2002). Structural remodelling in heart failure. Experimental and clinical cardiology, 7(2), 64-8.
Schaper, Jutta, et al. "Structural remodelling in heart failure." Experimental and clinical cardiology vol. 7,2 (2002): 64-8.
Schaper J, Kostin S, Hein S, Elsässer A, Arnon E, Zimmermann R. Structural remodelling in heart failure. Exp Clin Cardiol. 2002;7(2):64-8. PMID: 19649225; PMCID: PMC2719171.
Copy Download .nbib Format: NLM
Share it on

Exp Clin Cardiol. 2002;7(2):64-8.

Structural remodelling in heart failure.

Experimental and clinical cardiology

Jutta Schaper, Sawa Kostin, Stefan Hein, Albrecht Elsässer, Eyal Arnon, René Zimmermann

Affiliations

  1. Max Planck Institute, Bad Nauheim;

PMID: 19649225 PMCID: PMC2719171

Abstract

In the development of heart failure, extensive remodelling of the entire myocardium takes place. In this paper, findings on structural remodelling occurring in patients with severely reduced left ventricular function due to dilated cardiomyopathy are presented. This process involves all structural proteins of the myocytes; some of them are reduced (contractile proteins and most of the sarcomeric skeleton) and others are increased (cytoskeleton and membrane-associated proteins). Likewise, the connexin43 content of gap junctions is significantly reduced. The myocyte nuclei are enlarged by 20%, but the ratio of nuclear volume to cell volume is decreased. Nuclei contain less DNA and less of the splicing factor Sc-35 than normal myocardium, which might explain the depressed transcription and translation observed in failing hearts. The connective tissue including fibronectin, laminin and the different types of collagen is augmented, whereas the number of microvessels is decreased. This results in replacement fibrosis. Cell loss is caused by either ubiquitin-related autophagic cell death (most frequent) or by acute ischemic cell death (oncosis) but to a lesser degree by apoptosis. All of these modes of cell death contribute significantly to the loss of contractile function. The morphological alterations described here are the structural correlates of the typical clinical characteristics of heart failure in humans: reduced contractile function, increased ventricular stiffness and ventricular arrhythmias.

Keywords: Heart failure; Remodelling

References

  1. J Cell Sci. 2000 Apr;113 ( Pt 7):1189-98 - PubMed
  2. J Cell Sci. 2000 Nov;113 Pt 21:3851-9 - PubMed
  3. Circ Res. 2000 Apr 28;86(8):846-53 - PubMed
  4. N Engl J Med. 1996 Oct 17;335(16):1182-9 - PubMed
  5. Am J Pathol. 1995 Jan;146(1):3-15 - PubMed
  6. J Am Coll Cardiol. 2000 Mar 1;35(3):569-82 - PubMed
  7. Circulation. 1998 Feb 24;97(7):686-91 - PubMed
  8. Science. 1995 Oct 13;270(5234):293-6 - PubMed
  9. J Mol Cell Cardiol. 2000 May;32(5):711-24 - PubMed
  10. Histochem J. 1997 May;29(5):365-85 - PubMed
  11. Lab Invest. 1998 Jul;78(7):767-86 - PubMed
  12. Eur Heart J. 1997 Mar;18(3):470-9 - PubMed
  13. Cardioscience. 1994 Jun;5(2):127-38 - PubMed
  14. J Mol Cell Cardiol. 1994 Oct;26(10):1291-306 - PubMed
  15. J Clin Pathol. 1996 Jan;49(1):34-7 - PubMed
  16. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1725-9 - PubMed

Publication Types